XML 92 R79.htm IDEA: XBRL DOCUMENT v3.23.1
Derivatives and Hedge Accounting Activities (Schedule of Derivatives not Designated as Hedging Instruments) (Detail) - Derivatives Not Designated as Hedging Instruments - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] $ 342 $ (73)
Virginia Electric and Power Company    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (37) 16
Commodity Contract | Operating Revenue    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] 395 (330)
Commodity Contract | Operating Revenue | Virginia Electric and Power Company    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] 9 (41)
Commodity Contract | Purchased Gas    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] 94 2
Commodity Contract | Electric Fuel and Other Energy-Related Purchases    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (45) 59
Commodity Contract | Electric Fuel and Other Energy-Related Purchases | Virginia Electric and Power Company    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (46) 57
Interest Rate Contract | Interest And Related Charges    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] $ (102) $ 196
[1] Excludes amounts related to foreign currency exchange rate derivatives that are deferred to plant under construction within property, plant and equipment and regulatory assets/liabilities that will begin to amortize once the CVOW Commercial Project is placed in service.
[2] Includes derivative activity amortized out of regulatory assets/liabilities. Amounts deferred into regulatory assets/liabilities have no associated effect in the Companies' Consolidated Statements of Income.